The DOI matches its Crossref record; 154 of the 154 references it cites were found in a registry or an index.
The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer
Signoretti, S., Marcotullio, L. D., Richardson, A. L., Ramaswamy, S., Isaac, B. M., Rué, M., Monti, F., Loda, M. F., & Pagano, M. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15795 · Cited by 257
RetractedSlamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
Vivanco, I., & Sawyers, C. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc839 · Cited by 6,056
A microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
A MicroRNA Signature Associated with Prognosis and Progression in Chronic Lymphocytic Leukemia
Calin, G. A., Ferracin, M., Cimmino, A., Di Leva, G., Shimizu, M., Wojcik, S. E., Iorio, M. V., Visone, R., Sever, N. I., Fabbri, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050995 · Cited by 2,403
Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
Li, X., Lewis, M. T., Huang, J., Gutierrez, C., Osborne, C. K., Wu, M.-F., Hilsenbeck, S. G., Pavlick, A., Zhang, X., Chamness, G. C., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn123 · Cited by 1,794
Hirsch, F. R., Varella-Garcia, M., Bunn, P. A., Di Maria, M. V., Veve, R., Bremnes, R. M., Barón, A. E., Zeng, C., & Franklin, W. A. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.11.069 · Cited by 1,477
AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1
Medema, R. H., Kops, G. J. P. L., Bos, J. L., & Burgering, B. M. T. (2000) · Nature · doi:10.1038/35008115 · Cited by 1,438
Ubiquitin ligases: cell-cycle control and cancer
Nakayama, K. I., & Nakayama, K. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1881 · Cited by 1,433
New functional activities for the p21 family of CDK inhibitors.
LaBaer, J., Garrett, M. D., Stevenson, L. F., Slingerland, J. M., Sandhu, C., Chou, H. S., Fattaey, A., & Harlow, E. (1997) · Genes & Development · doi:10.1101/gad.11.7.847 · Cited by 1,402
Self-citationCheng, M., Olivier, P., Diehl, J. A., Fero, M., Roussel, M. F., Roberts, J. M., & Sherr, C. J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.6.1571 · Cited by 1,142 · cited 1×
“Both p27 and p21 facilitate assembly of D-type cyclin complexes in vitro and in vivo and direct their nuclear impor”
BackgroundLoda, M., Cukor, B., Tam, S. W., Lavin, P., Fiorentinc, M., Draetta, G. F., Jessup, J. M., & Pagano, M. (1997) · Nature Medicine · doi:10.1038/nm0297-231 · Cited by 1,031
PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest
Liang, J., Zubovitz, J., Petrocelli, T., Kotchetkov, R., Connor, M. K., Han, K., Lee, J.-H., Ciarallo, S., Catzavelos, C., Beniston, R., et al. (2002) · Nature Medicine · doi:10.1038/nm761 · Cited by 948
Self-citationNagahara, H., Vocero-Akbani, A. M., Snyder, E. L., Ho, A., Latham, D. G., Lissy, N. A., Becker-Hapak, M., Ezhevsky, S. A., & Dowdy, S. F. (1998) · Nature Medicine · doi:10.1038/4042 · Cited by 928
Crystal structure of the p27Kip1 cyclin-dependent-kinase inibitor bound to the cyclin A–Cdk2 complex
Russo, A. A., Jeffrey, P. D., Patten, A. K., Massagué, J., & Pavletich, N. P. (1996) · Nature · doi:10.1038/382325a0 · Cited by 907
Porter, P. L., Malone, K. E., Heagerty, P. J., Alexander, G. M., Gatti, L. A., Firpo, E. J., Daling, J. R., & Roberts, J. M. (1997) · Nature Medicine · doi:10.1038/nm0297-222 · Cited by 901
Multiple Roles of the PI3K/PKB (Akt) Pathway in Cell Cycle Progression
Liang, J., & Slingerland, J. M. (2003) · Cell Cycle · doi:10.4161/cc.2.4.433 · Cited by 885
Self-citationLiang, J., Shao, S. H., Xu, Z.-X., Hennessy, B., Ding, Z., Larrea, M., Kondo, S., Dumont, D. J., Gutterman, J. U., Walker, C. L., et al. (2007) · Nature Cell Biology · doi:10.1038/ncb1537 · Cited by 866
Self-citationTranslational Control of p27 Kip1 Accumulation During the Cell Cycle
Hengst, L., & Reed, S. I. (1996) · Science · doi:10.1126/science.271.5257.1861 · Cited by 846
Self-citationCatzavelos, C., Bhattacharya, N., Ung, Y. C., Wilson, J. A., Roncari, L., Sandhu, C., Shaw, P., Yeger, H., Morava-Protzner, I., Kapusta, L., et al. (1997) · Nature Medicine · doi:10.1038/nm0297-227 · Cited by 823
Self-citationShin, I., Yakes, F. M., Rojo, F., Shin, N.-Y., Bakin, A. V., Baselga, J., & Arteaga, C. L. (2002) · Nature Medicine · doi:10.1038/nm759 · Cited by 790
Galardi, S., Mercatelli, N., Giorda, E., Massalini, S., Frajese, G. V., Ciafre, S. A., & Farace, M. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701805200 · Cited by 749
Pavletich, N. P. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2640 · Cited by 744
RNA-Binding Protein Dnd1 Inhibits MicroRNA Access to Target mRNA
Kedde, M., Strasser, M. J., Boldajipour, B., Vrielink, J. A. F. O., Slanchev, K., le Sage, C., Nagel, R., Voorhoeve, P. M., van Duijse, J., Ørom, U. A., et al. (2007) · Cell · doi:10.1016/j.cell.2007.11.034 · Cited by 732
Viglietto, G., Motti, M. L., Bruni, P., Melillo, R. M., D'Alessio, A., Califano, D., Vinci, F., Chiappetta, G., Tsichlis, P., Bellacosa, A., et al. (2002) · Nature Medicine · doi:10.1038/nm762 · Cited by 701
Regulation of the Cdk inhibitor p27 and its deregulation in cancer
Slingerland, J., & Pagano, M. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200004)183:1<10::aid-jcp2>3.0.co;2-i · Cited by 695
Self-citationDonato, N. J., Wu, J. Y., Stapley, J., Gallick, G., Lin, H., Arlinghaus, R., & Talpaz, M. (2003) · Blood · doi:10.1182/blood.v101.2.690 · Cited by 663
Germ-line mutations in p27 Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans
Pellegata, N. S., Quintanilla-Martinez, L., Siggelkow, H., Samson, E., Bink, K., Höfler, H., Fend, F., Graw, J., & Atkinson, M. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603877103 · Cited by 644
Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1
Tomoda, K., Kubota, Y., & Kato, J.-Y. (1999) · Nature · doi:10.1038/18230 · Cited by 632
p21-containing cyclin kinases exist in both active and inactive states.
Zhang, H., Hannon, G. J., & Beach, D. (1994) · Genes & Development · doi:10.1101/gad.8.15.1750 · Cited by 632
c-Src and cooperating partners in human cancer
Ishizawar, R., & Parsons, S. J. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.001 · Cited by 617 · cited 1×
“Epidermal growth factor receptor ( EGFR ) and ERBB2 both bind SRC to catalyse mutual kinase activatio”
BackgroundDijkers, P. F., Medema, R. H., Pals, C., Banerji, L., Thomas, N. S. B., Lam, E. W.-F., Burgering, B. M. T., Raaijmakers, J. A. M., Lammers, J.-W. J., Koenderman, L., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.24.9138-9148.2000 · Cited by 617
Skp2 is oncogenic and overexpressed in human cancers
Gstaiger, M., Jordan, R., Lim, M., Catzavelos, C., Mestan, J., Slingerland, J., & Krek, W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081474898 · Cited by 505
Self-citationCheng, M., Sexl, V., Sherr, C. J., & Roussel, M. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.3.1091 · Cited by 496
Steroid hormone receptors in breast cancer management
Osborne, C. K. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1006132427948 · Cited by 438
Amann, J., Kalyankrishna, S., Massion, P. P., Ohm, J. E., Girard, L., Shigematsu, H., Peyton, M., Juroske, D., Huang, Y., Stuart Salmon, J., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.226.65.1 · Cited by 436
Impaired Control of IRES-Mediated Translation in X-Linked Dyskeratosis Congenita
Yoon, A., Peng, G., Brandenburg, Y., Zollo, O., Xu, W., Rego, E., & Ruggero, D. (2006) · Science · doi:10.1126/science.1123835 · Cited by 424
Visone, R., Russo, L., Pallante, P., De Martino, I., Ferraro, A., Leone, V., Borbone, E., Petrocca, F., Alder, H., Croce, C. M., et al. (2007) · Endocrine-Related Cancer · doi:10.1677/erc-07-0129 · Cited by 417
Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer.
Esposito, V., Baldi, A., Luca, A. D., Gröger, A. M., Loda, M. F., Giordano, G. G., Caputi, M., Baldi, F., Pagano, M., & Giordano, A. (1997) · PubMed · Cited by 415
Karnik, S. K., Hughes, C. M., Gu, X., Rozenblatt-Rosen, O., McLean, G. W., Xiong, Y., Meyerson, M., & Kim, S. K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503484102 · Cited by 403
Identification of a tumour suppressor network opposing nuclear Akt function
Trotman, L. C., Alimonti, A., Scaglioni, P. P., Koutcher, J. A., Cordon-Cardo, C., & Pandolfi, P. P. (2006) · Nature · doi:10.1038/nature04809 · Cited by 394
Deregulated degradation of the cdk inhibitor p27 and malignant transformation
Bloom, J., & Pagano, M. (2003) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00098-6 · Cited by 374
p27 Phosphorylation by Src Regulates Inhibition of Cyclin E-Cdk2
Chu, I., Sun, J., Arnaout, A., Kahn, H., Hanna, W., Narod, S., Sun, P., Tan, C.-K., Hengst, L., & Slingerland, J. (2007) · Cell · doi:10.1016/j.cell.2006.11.049 · Cited by 372
Self-citationSkp2-Mediated Degradation of p27 Regulates Progression into Mitosis
Nakayama, K., Nagahama, H., Minamishima, Y. A., Miyake, S., Ishida, N., Hatakeyama, S., Kitagawa, M., Iemura, S.-I., Natsume, T., & Nakayama, K. I. (2004) · Developmental Cell · doi:10.1016/s1534-5807(04)00131-5 · Cited by 364
Foulkes, W. D., Brunet, J.-S., Stefansson, I. M., Straume, O., Chappuis, P. O., Bégin, L. R., Hamel, N., Goffin, J. R., Wong, N., Trudel, M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2970 · Cited by 363
Akt-dependent Phosphorylation of p27Kip1Promotes Binding to 14-3-3 and Cytoplasmic Localization
Fujita, N., Sato, S., Katayama, K., & Tsuruo, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203668200 · Cited by 358
Cdk-Inhibitory Activity and Stability of p27 Are Directly Regulated by Oncogenic Tyrosine Kinases
Grimmler, M., Wang, Y., Mund, T., Cilenšek, Z., Keidel, E.-M., Waddell, M. B., Jäkel, H., Kullmann, M., Kriwacki, R. W., & Hengst, L. (2007) · Cell · doi:10.1016/j.cell.2006.11.047 · Cited by 337
Self-citationELAV/Hu proteins inhibit p27 translation via an IRES element in the p27 5′UTR
Kullmann, M., Göpfert, U., Siewe, B., & Hengst, L. (2002) · Genes & Development · doi:10.1101/gad.248902 · Cited by 327
Self-citationTsihlias, J., Kapusta, L. R., Deboer, G., Morava-Protzner, I., Zbieranowski, I., Bhattacharya, N., Catzavelos, G. C., Lh, K., & Slingerland, J. (1998) · PubMed · Cited by 325
Self-citationThe Prognostic Significance of Altered Cyclin-Dependent Kinase Inhibitors in Human Cancer
Tsihlias, M., Kapusta, M., & Slingerland, M. (1999) · Annual Review of Medicine · doi:10.1146/annurev.med.50.1.401 · Cited by 319
Cordon-Cardo, C., Koff, A., Drobnjak, M., Capodieci, P., Osman, I., Millard, S. S., Gaudin, P. B., Fazzari, M., Zhang, Z.-F., Massague, J., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.17.1284 · Cited by 300
P27kip1 Down-Regulation Is Associated with Trastuzumab Resistance in Breast Cancer Cells
Nahta, R., Takahashi, T., Ueno, N. T., Hung, M.-C., & Esteva, F. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3900 · Cited by 298
Lane, H. A., Beuvink, I., Motoyama, A. B., Daly, J. M., Neve, R. M., & Hynes, N. E. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.9.3210-3223.2000 · Cited by 298
Rodier, G. (2001) · The EMBO Journal · doi:10.1093/emboj/20.23.6672 · Cited by 286
A growth factor-dependent nuclear kinase phosphorylates p27Kip1 and regulates cell cycle progression
Boehm, M. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf343 · Cited by 285
Role of the RNA-binding protein HuR in colon carcinogenesis
de Silanes, I. L., Fan, J., Yang, X., Zonderman, A. B., Potapova, O., Pizer, E. S., & Gorospe, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206862 · Cited by 282
Role of the F-box protein Skp2 in lymphomagenesis
Latres, E., Chiarle, R., Schulman, B. A., Pavletich, N. P., Pellicer, A., Inghirami, G., & Pagano, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041475098 · Cited by 279
LOW P27 EXPRESSION PREDICTS POOR DISEASE-FREE SURVIVAL IN PATIENTS WITH PROSTATE CANCER
YANG, R. M., NAITOH, J., MURPHY, M., WANG, H.-J., PHILLIPSON, J., DEKERNION, J. B., LODA, M., & REITER, R. E. (1998) · Journal of Urology · doi:10.1016/s0022-5347(01)63776-5 · Cited by 278
p27Kip1-stathmin interaction influences sarcoma cell migration and invasion
Baldassarre, G., Belletti, B., Nicoloso, M. S., Schiappacassi, M., Vecchione, A., Spessotto, P., Morrione, A., Canzonieri, V., & Colombatti, A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.025 · Cited by 277
Repression of transcription of the p27Kip1 cyclin-dependent kinase inhibitor gene by c-Myc
Yang, W., Shen, J., Wu, M., Arsura, M., FitzGerald, M., Suldan, Z., Kim, D. W., Hofmann, C. S., Pianetti, S., Romieu-Mourez, R., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204245 · Cited by 277
Phosphorylation of p27 on Serine 10 Is Required for Its Binding to CRM1 and Nuclear Export
Ishida, N., Hara, T., Kamura, T., Yoshida, M., Nakayama, K., & Nakayama, K. I. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100762200 · Cited by 264
Her-2/neu as a Predictive Marker of Response to Breast Cancer Therapy
Pegram, M. D., Pauletti, G., & Slamon, D. J. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1006111117877 · Cited by 259
Malek, N. P., Sundberg, H., McGrew, S., Nakayama, K., Kyriakidis, T. R., & Roberts, J. M. (2001) · Nature · doi:10.1038/35095083 · Cited by 252
Chu, I., Blackwell, K., Chen, S., & Slingerland, J. (2005) · Cancer Research · doi:10.1158/0008-5472.18.65.1 · Cited by 251
Self-citationOncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer
Signoretti, S., Di Marcotullio, L., Richardson, A., Ramaswamy, S., Isaac, B., Rue, M., Monti, F., Loda, M., & Pagano, M. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215795 · Cited by 245
Formation of p27-CDK complexes during the human mitotic cell cycle.
Soos, T. J., Kiyokawa, H., Yan, J. S., Rubin, M. S., Giordano, A., DeBlasio, A., Bottega, S., Wong, B., Mendelsohn, J. M., & Koff, A. (1996) · PubMed · Cited by 239
Targets of cyclin-dependent protein kinases
Nigg, E. A. (1993) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(93)90101-u · Cited by 234
Cariou, S., Donovan, J. C. H., Flanagan, W. M., Milic, A., Bhattacharya, N., & Slingerland, J. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160016897 · Cited by 224
Self-citationBesson, A., Gurian-West, M., Chen, X., Kelly-Spratt, K. S., Kemp, C. J., & Roberts, J. M. (2006) · Genes & Development · doi:10.1101/gad.1384406 · Cited by 218
Chiarle, R., Budel, L. M., Skolnik, J., Frizzera, G., Chilosi, M., Corato, A., Pizzolo, G., Magidson, J., Montagnoli, A., Pagano, M., et al. (2000) · Blood · doi:10.1182/blood.v95.2.619 · Cited by 216
McAllister, S. S., Becker-Hapak, M., Pintucci, G., Pagano, M., & Dowdy, S. F. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.216-228.2003 · Cited by 212
Fujita, N., Sato, S., & Tsuruo, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306614200 · Cited by 209
Besson, A., Hwang, H. C., Cicero, S., Donovan, S. L., Gurian-West, M., Johnson, D., Clurman, B. E., Dyer, M. A., & Roberts, J. M. (2007) · Genes & Development · doi:10.1101/gad.1556607 · Cited by 208
Busse, D., Doughty, R. S., Ramsey, T. T., Russell, W. E., Price, J. O., Flanagan, W. M., Shawver, L. K., & Arteaga, C. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.10.6987 · Cited by 205
Hes1 Directly Controls Cell Proliferation through the Transcriptional Repression of p27Kip1
Murata, K., Hattori, M., Hirai, N., Shinozuka, Y., Hirata, H., Kageyama, R., Sakai, T., & Minato, N. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.10.4262-4271.2005 · Cited by 200
Androgen receptor gene and hormonal therapy failure of prostate cancer.
Koivisto, P. A., Kolmer, M., Visakorpi, T., & Kallioniemi, O. (1998) · Europe PMC (PubMed Central) · Cited by 196
Skp2-dependent degradation of p27kip1 is essential for cell cycle progression
Kossatz, U., Dietrich, N., Zender, L., Buer, J., Manns, M. P., & Malek, N. P. (2004) · Genes & Development · doi:10.1101/gad.321004 · Cited by 194
Myc-enhanced expression of Cul1 promotes ubiquitin-dependent proteolysis and cell cycle progression
O'Hagan, R. C., Ohh, M., David, G., de Alboran, I. M., Alt, F. W., Kaelin, W. G., & DePinho, R. A. (2000) · Genes & Development · doi:10.1101/gad.827200 · Cited by 194
Millard, S. S., Yan, J. S., Nguyen, H., Pagano, M., Kiyokawa, H., & Koff, A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.11.7093 · Cited by 193
Cote, R. J., Shi, Y., Groshen, S. G., Feng, A., Skinner, D. G., Lieskovosky, G., & Cordon‐Cardo, C. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.12.916 · Cited by 191
Regulation of the cytoskeleton: an oncogenic function for cdk inhibitors?
Besson, A., Assoian, R. K., & Roberts, J. M. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1501 · Cited by 189
Inhibitors of the Cip/Kip Family
Hengst, L., & Reed, S. I. (1998) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-71941-7_2 · Cited by 188
Self-citationConnor, M. K., Kotchetkov, R., Cariou, S., Resch, A., Lupetti, R., Beniston, R. G., Melchior, F., Hengst, L., & Slingerland, J. M. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-06-0319 · Cited by 182
Self-citationRepression of p27 kip1 Synthesis by Platelet-Derived Growth Factor in BALB/c 3T3 Cells
Agrawal, D., Hauser, P., McPherson, F., Dong, F., Garcia, A., & Pledger, W. J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.8.4327 · Cited by 168
Inoue, T., Kamiyama, J., & Sakai, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32309 · Cited by 160
14‐3‐3 suppresses the nuclear localization of threonine 157‐phosphorylated p27Kip1
Sekimoto, T., Fukumoto, M., & Yoneda, Y. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600198 · Cited by 159
Denkert, C., Weichert, W., Pest, S., Koch, I., Licht, D., Köbel, M., Reles, A., Sehouli, J., Dietel, M., & Hauptmann, S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1987 · Cited by 159
Gene Expression Profiling of Breast Cancer: A New Tumor Marker
van't Veer, L. J., Paik, S., & Hayes, D. F. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.12.005 · Cited by 158
Wang, X., Krupczak-Hollis, K., Tan, Y., Dennewitz, M. B., Adami, G. R., & Costa, R. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207510200 · Cited by 154
The Cyclin-dependent Kinase Inhibitor p27Kip1 Is Stabilized in G0 by Mirk/dyrk1B Kinase
Deng, X., Mercer, S. E., Shah, S., Ewton, D. Z., & Friedman, E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400479200 · Cited by 148
Erkinheimo, T.-L., Lassus, H. J., Sivula, A., Sengupta, S., Furneaux, H., Hla, T., Haglund, C. H., Bützow, R. C., & Ristimaki, A. P. (2003) · PubMed · Cited by 145
Andreu, E. J., Lledó, E., Poch, E., Ivorra, C., Albero, M. P., Martinez-Climent, J. A., Montiel‐Duarte, C., Rifón, J., Pérez‐Calvo, J., Arbona, C., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1357 · Cited by 144
Donovan, J. C. H., Milic, A., & Slingerland, J. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106448200 · Cited by 137
Self-citationThe prognostic impact of the ubiquitin ligase subunits Skp2 and Cks1 in colorectal carcinoma
Shapira, M., Ben‐Izhak, O., Linn, S., Futerman, B., Minkov, I., & Hershko, D. (2005) · Cancer · doi:10.1002/cncr.20917 · Cited by 135
A U-Rich Element in the 5′ Untranslated Region Is Necessary for the Translation of p27 mRNA
Millard, S. S., Vidal, A., Markus, M., & Koff, A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.16.5947-5959.2000 · Cited by 135
Differential Modification of p27 Kip1 Controls Its Cyclin D-cdk4 Inhibitory Activity
James, M. K., Ray, A., Leznova, D., & Blain, S. W. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02171-06 · Cited by 134
Reduction of Cytosolic p27Kip1 Inhibits Cancer Cell Motility, Survival, and Tumorigenicity
Wu, F. Y., Wang, S. E., Sanders, M. E., Shin, I., Rojo, F., Baselga, J. M., & Arteaga, C. L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3304 · Cited by 130
Yang, H.-Y., Zhou, B. P., Hung, M., & Lee, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000147200 · Cited by 122
Catzavelos, C., Tsao, M., DeBoer, G., Bhattacharya, N., Shepherd, F. A., & Slingerland, J. M. (1999) · PubMed · Cited by 122
Self-citationChappuis, P. O., Kapusta, L. R., Bégin, L. R., Wong, N., Brunet, J., Narod, S. A., Slingerland, J. M., & Foulkes, W. D. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.24.4045 · Cited by 120
Self-citationHauck, L., Harms, C., An, J., Rohne, J., Gertz, K. R., Dietz, R., Endres, M., & von Harsdorf, R. (2008) · Nature Medicine · doi:10.1038/nm1729 · Cited by 115
Determination of Molecular Marker Expression Can Predict Clinical Outcome in Colon Carcinomas
Galizia, G., Lieto, E., Ferraraccio, F., Orditura, M., Vita, F. D., Castellano, P., Imperatore, V., Romano, C. P., Ciardiello, F., Agostini, B., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0960-03 · Cited by 115
p27KIP1 in human lung cancers: differential changes in small cell and non-small cell carcinomas.
Yatabe, Y., Masuda, A., Koshikawa, T., Nakamura, S., Kuroishi, T., Osada, H., Takahashi, T., Mitsudomi, T., & Takahashi, T. (1998) · PubMed · Cited by 111
Relocalized p27Kip1 Tumor Suppressor Functions as a Cytoplasmic Metastatic Oncogene in Melanoma
Denicourt, C., Saenz, C. C., Datnow, B., Cui, X.-S., & Dowdy, S. F. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1375 · Cited by 111
Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers.
Hommura, F., Dosaka‐Akita, H., Mishina, T., Nishi, M., Kojima, T., Hiroumi, H., Ogura, S., Shimizu, M., Katoh, H., & Kawakami, Y. (2000) · PubMed · Cited by 110
Cul4A and DDB1 Associate with Skp2 To Target p27Kip1 for Proteolysis Involving the COP9 Signalosome
Bondar, T., Kalinina, A., Khair, L., Kopanja, D., Nag, A., Bagchi, S., & Raychaudhuri, P. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.7.2531-2539.2006 · Cited by 107
Shin, I., Rotty, J. D., Wu, F. Y., & Arteaga, C. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m412367200 · Cited by 105
Sui, L., Dong, Y., Ohno, M., Sugimoto, K., Tai, Y., Hando, T., & Tokuda, M. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2001.6308 · Cited by 103
Myc targets Cks1 to provoke the suppression of p27Kip1, proliferation and lymphomagenesis
Keller, U. B., Old, J. B., Dorsey, F. C., Nilsson, J. A., Nilsson, L. M., Maclean, K. H., Chung, L., Yang, C., Spruck, C., Boyd, K. L., et al. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601691 · Cited by 101
Expression of p27kip1 in prostatic adenocarcinoma.
Cheville, J. C., Lloyd, R. V., Sebo, T. J., Cheng, L., Erickson, L. A., Bostwick, D. G., Lohse, C. M., & Wollan, P. C. (1998) · PubMed · Cited by 101
Regulation of p27 Degradation and S-Phase Progression by Ro52 RING Finger Protein
Sabile, A., Meyer, A. M., Wirbelauer, C., Heß, D., Kogel, U., Scheffner, M., & Krek, W. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01630-05 · Cited by 99
Arteaga, C. L., & Baselga, J. M. (2003) · PubMed · Cited by 96
Control of Cyclin-Dependent Kinase Inhibitor p27 Expression by Cap-Independent Translation
Miskimins, W. K., Wang, G., Hawkinson, M., & Miskimins, R. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.15.4960-4967.2001 · Cited by 95
Pirh2 Promotes Ubiquitin-Dependent Degradation of the Cyclin-Dependent Kinase Inhibitor p27 Kip1
Hattori, T., Isobe, T., Abe, K., Kikuchi, H., Kitagawa, K., Oda, T., Uchida, C., & Kitagawa, M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2033 · Cited by 91
Vidal, A., Millard, S. S., Miller, J. P., & Koff, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112090200 · Cited by 86
Yang, H., Zhao, R., Yang, H.-Y., & Lee, M. (2005) · Oncogene · doi:10.1038/sj.onc.1208352 · Cited by 84
Cho, S., Kim, J. H., Back, S. H., & Jang, S. K. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.4.1283-1297.2005 · Cited by 81
C‐terminal phosphorylation controls the stability and function of p27kip1
Kossatz-Boehlert, U., Vervoorts, J., Nickeleit, I., Sundberg, H., Arthur, J. S. C., Manns, M. P., & Malek, N. P. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601388 · Cited by 80
Activation of p27Kip1 Expression by E2F1
Wang, C., Hou, X., Mohapatra, S., Ma, Y., Cress, W. D., Pledger, W. J., & Chen, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c400536200 · Cited by 79
Prognostic Value of p27Kip1 and CyclinD1 Expression in Esophageal Cancer
Itami, A., Shimada, Y., Watanabe, G., & Imamura, M. (1999) · Oncology · doi:10.1159/000012067 · Cited by 76
Prognostic role of p27Kip1 and apoptosis in human breast cancer
Wu, J., Shen, Z.-Z., Lu, J.-S., Jiang, M., Qx, H., Fontana, J. A., Barsky, S. H., & Shao, Z.-M. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690250 · Cited by 72
Porter, P. L., Barlow, W. E., Yeh, I., Lin, M. G., Yuan, X., Donato, E., Sledge, G. W., Shapiro, C. L., Ingle, J. N., Haskell, C. M., et al. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj467 · Cited by 72
Shintani, S., Li, C., Mihara, M., Hino, S., Nakashiro, K., & Hamakawa, H. (2003) · Oncology · doi:10.1159/000074649 · Cited by 70
Kotake, Y., Nakayama, K., Ishida, N., & Nakayama, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406117200 · Cited by 70
Anayama, T., Furihata, M., Ishikawa, T., Ohtsuki, Y., & Ogoshi, S. (1998) · International Journal of Cancer · Cited by 67
Akt-Dependent T198 Phosphorylation of Cyclin-Dependent Kinase Inhibitor p27kip1in Breast Cancer
Motti, M. L., Marco, C. D., Califano, D., Fusco, A., & Viglietto, G. (2004) · Cell Cycle · doi:10.4161/cc.3.8.1073 · Cited by 67
Göpfert, U., Kullmann, M., & Hengst, L. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg177 · Cited by 66
Self-citationGillett, C., Smith, P., Peters, G. G., Lü, X., & Barnes, D. M. (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199901)187:2<200::aid-path228>3.0.co;2-m · Cited by 64
Diverse Ways to Control p27Kip1 Function: miRNAs Come into Play
le Sage, C., Nagel, R., & Agami, R. (2007) · Cell Cycle · doi:10.4161/cc.6.22.4900 · Cited by 62
Minimal Requirements for the Nuclear Localization of p27Kip1, a Cyclin-Dependent Kinase Inhibitor
Zeng, Y., Hirano, K., Hirano, M., Nishimura, J., & Kanaide, H. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3098 · Cited by 62
Georgitsi, M., Karhu, A., Winqvist, R., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603573 · Cited by 59
Tenjo, T., Toyoda, M., Okuda, J., Watanabe, I., Yamamoto, T., Tanaka, K., Ohtani, M., Nohara, T., Kawasaki, H., & Tanigawa, N. (2000) · Oncology · doi:10.1159/000012078 · Cited by 57
Korkolopoulou, P. A., Vassilopoulos, I., Konstantinidou, A. E., et al. (2002) · Gynecologic Oncology · doi:10.1006/gyno.2002.6627 · Cited by 57
Disruption of TGF-β growth inhibition by oncogenic ras is linked to p27Kip1 mislocalization
Liu, X., Sun, Y., Ehrlich, M., Lu, T., Kloog, Y., Weinberg, R. A., Lodish, H. F., & Henis, Y. I. (2000) · Oncogene · doi:10.1038/sj.onc.1203991 · Cited by 57
Pohl, G., Rudas, M., Dietze, O., Lax, S., Markis, E., Pirker, R., Zielinski, C. C., Hausmaninger, H., Kubista, E., Samonigg, H., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.021 · Cited by 53
Baekelandt, M. M. O., Holm, R., Tropé, C. G., Nesland, J. M., & Kristensen, G. B. (1999) · PubMed · Cited by 52
Reed, W., Flørenes, V. A., Holm, R., Hannisdal, E., & Nesland, J. M. (1999) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280050408 · Cited by 51
Cheng, J. D., Werness, B. A., Babb, J. S., & Meropol, N. J. (1999) · PubMed · Cited by 50
Correlation of p27 protein expression with HER‐2/neu expression in breast cancer
Newman, L. A., Xia, W., Yang, H.-Y., Sahin, A., Bondy, M. L., Lukmanji, F., Hung, M., & Lee, M. (2001) · Molecular Carcinogenesis · doi:10.1002/mc.1025 · Cited by 49
Rosati, G., Chiacchio, R., Reggiardo, G., Sanctis, D. D., & Manzione, L. (2004) · Tumor Biology · doi:10.1159/000081389 · Cited by 43
p27 Expression Correlates with Short-Term, but not with Long-Term Prognosis in Breast Cancer
Leivonen, M., Nordling, S., Lundin, J. E., von Boguslawski, K., & Haglund, C. H. (2001) · Breast Cancer Research and Treatment · doi:10.1023/a:1010623326118 · Cited by 40
Ishihara, S., Minato, K., Hoshino, H., Saito, R., Hara, F., Nakajima, T., & Mori, M. (1999) · Lung Cancer · doi:10.1016/s0169-5002(99)00085-9 · Cited by 39
Psyrri, A. K., Bamias, A., Yu, Z., Weinberger, P., Kassar, M., Markakis, S., Kowalski, D. P., Efstathiou, E., Camp, R. L., Rimm, D. L., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1270 · Cited by 38
Nohara, T., Toshio, R. Y. O., IWAMOTO, S., Gon, G., & Tanigawa, N. (2000) · Oncology · doi:10.1159/000055303 · Cited by 37
Zheng, W., Zheng, J., Ma, R., Meng, F., & NI, C. (2005) · Steroids · doi:10.1016/j.steroids.2005.04.012 · Cited by 35
Kardinal, C., Dangers, M., Kardinal, A., Koch, A., Brandt, D. T., Tamura, T., & Welte, K. (2005) · Blood · doi:10.1182/blood-2005-05-1771 · Cited by 34
Loss of E‐cadherin and p27 expression is associated with head and neck squamous tumorigenesis
Massarelli, E., Brown, E. N., Ngoc, T., Liu, D. D., Izzo, J. G., Lee, J. J., El‐Naggar, A. K., Hong, W. K., & Papadimitrakopoulou, V. A. (2005) · Cancer · doi:10.1002/cncr.20879 · Cited by 26
Belluco, C., Esposito, G., Bertorelle, R., Mistro, A. D., Fassina, A., Vieceli, G., Chieco‐Bianchi, L., Nitti, D., & Lise, M. (1999) · Annals of Surgical Oncology · doi:10.1007/s10434-999-0019-2 · Cited by 25
Fontanière, S., Casse, H., Bertolino, P., & Zhang, C. X. (2006) · Familial Cancer · doi:10.1007/s10689-005-2575-3 · Cited by 21
Inactivation of PTEN is associated with a low p27Kip1 protein expression in breast carcinoma
Tsutsui, S., Inoue, H., Yasuda, K., Suzuki, K., Tahara, K., Higashi, H., Era, S., & Mori, M. (2005) · Cancer · doi:10.1002/cncr.21471 · Cited by 18
Inhibition of Cdk4 Activity Enhances Translation of p27 in Quiescent Rb-negative Cells
González, T., Seoane, M., Caamaño, P., Viñuela, J. E., Domı́nguez, F., & Zalvide, J. B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207530200 · Cited by 16
Watson, N. F. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i39.6299 · Cited by 14
Cited by
The history and future of targeting cyclin-dependent kinases in cancer therapy
Asghar, U., Witkiewicz, A. K., Turner, N. C., & Knudsen, E. S. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4504 · Cited by 1,767
The landscape of cancer genes and mutational processes in breast cancer
The Oslo Breast Cancer Consortium (OSBREAC), Stephens, P. J., Tarpey, P. S., Davies, H., Van Loo, P., Greenman, C., Wedge, D. C., Nik-Zainal, S., Martin, S., Varela, I., et al. (2012) · Nature · doi:10.1038/nature11017 · Cited by 1,698
Biological determinants of endocrine resistance in breast cancer
Musgrove, E. A., & Sutherland, R. L. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2713 · Cited by 1,252
Global signatures of protein and mRNA expression levels
de Sousa Abreu, R., Penalva, L. O., Marcotte, E. M., & Vogel, C. (2009) · Molecular BioSystems · doi:10.1039/b908315d · Cited by 1,248
Mechanisms of Endocrine Resistance in Breast Cancer
Osborne, C. K., & Schiff, R. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-070909-182917 · Cited by 1,166
Metadata
- Authors
- Chu, I. M., Hengst, L., & Slingerland, J. M.
- Venue
- Nature Reviews Cancer
- Published
- 2008-04
- Volume
- 8
- Issue
- 4
- Pages
- 253-267
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2049283940
- Cited by
- 990
- References
- 154
- FWCI
- 4.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.